Searched for
GLIMEPIRIDE PIOGLITAZONE METFORMIN FDC
16 fixed-dose combination drugs banned in India: Check full list hereFixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
- US drugs site TrumpRx to list 600 generics as Donald Trump targets lower pricesPresident Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...
- PCOS now PMOS: Health condition that affects every eighth woman renamed after 14 years of misunderstandingPolycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its systemic impact bey...
- Supreme Court seeks Centre's response on Micro Labs' plea against diabetes drug banThe Supreme Court has asked the Centre and the Drug Controller General of India to respond to Micro Labs' appeal against a ban on two fixed...
- Delhi HC restores ban on 2 diabetes FDCsThe Delhi High Court has made waves with its recent judgment, reinstating a ban on two fixed-dose combination drugs for managing Type II Di...
- Regulator bans 35 combination drugs over safety issuesIndia's drug regulator has banned the manufacture and sale of 35 fixed dose combinations (FDCs), citing concerns over patient safety and po...
- Akums gets DCGI nod for triple combination diabetes medicationAkums Drugs and Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) for a triple combination diabetes me...
- Glenmark Pharmaceuticals rises 5% on launching first 3-drug FDC for type-2 diabetes in India“This FDC has been launched under the brand name Zita®-PioMet,” the company said in a BSE filing. “This offers patients with Type 2 diabete...
- Glenmark launches unique fixed dose combination drug for diabetesThe Mumbai based drug firm said it has introduced fixed dose combination (FDC) of its novel, patent protected Sodium Glucose Co-Transporter...
- NPPA fixes price caps for 12 anti-diabetic medicinesThese include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet. The ...
- Drug pricing regulator fixes prices of 40 formulation drugsThe regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combinati...
- Unichem, Macleods Pharma recall drugs from US marketDrug firms Unichem Pharmaceuticals and Macleods Pharma are recalling various lots of tablets used for treatment of high blood pressure and ...
- Anti-diabetic drug tops India's pharma salesIn a grim reminder of the rise of lifestyle diseases, anti-diabetic molecule has for the first time become the largest-selling formulation ...
- Diabetes drug ban to help companies like USV, Sun Pharma, LupinIn the wake of a government ban on top-selling diabetes drug, pioglitazone , the volumes are expected to shift to other classes such as fir...
- Health ministry bans two drugs Analgin and Pioglitazone; industry protestsThe health ministry has suspended the sale of two drugs - painkiller Analgin and anti-diabetes drug Pioglitazone and all its combinations.
- Aurobindo Pharma gets USFDA nod for anti-diabetes drugMedicines are indicated as an addition to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus.
- Aurobindo Pharma gets tentative nod from USFDA for diabetes drug Actoplus MetAurobindo Pharma said it has received tentative approval from US health regulator for its generic version of diabetes drug Actoplus Met tab...
- Aventis Pharma, Themis sign tech dealAventis Pharma and Themis Laboratories have signed a technology transfer agreement for fixed-dose combinations comprising glibenclamide (Da...
Load More
